About the News Conference
Leading national infectious disease experts presented final influenza (flu) vaccine coverage data from the 2021-2022 US flu season and discussed the importance of vaccination against flu and pneumococcal disease, particularly among older adults and those with chronic health conditions who are at higher risk for related complications.
Results from a new NFID national survey of US adults were also shared on vaccination attitudes and behaviors, including the impacts of the COVID-19 pandemic, at the 2022 National Foundation for Infectious Diseases (NFID) Influenza/Pneumococcal Disease News Conference on Tuesday, October 4, 2022.
Panelists included: Tamika C. Auguste, MD, ACOG Fellow and Chair, Women’s and Infants’ Services, MedStar Washington Hospital Center; William Schaffner, MD, NFID Medical Director; Patricia (Patsy) A. Stinchfield, RN, MS, CPNP, NFID President (Moderator); Jeb S. Teichman, MD, Retired Pediatrician and Healthcare Executive; and Rochelle P. Walensky, MD, MPH, Centers for Disease Control and Prevention (CDC) Director, with additional expert Alicia M. Fry, MD, MPH, Chief, Epidemiology and Prevention Branch, Influenza Division, CDC.
Press Kit Information
View the conference press release, agenda, panelist bios, as well as related resources below.
2021 National Survey: Attitudes about Influenza, Pneumococcal Disease, and COVID-19
NFID 2021 National Survey on flu and pneumococcal disease including the impact of COVID-19
National Survey: Black Adult Perspectives on COVID-19 and Flu Vaccines
Results from a 2020 national survey of US Black adults commissioned to better understand beliefs about COVID-19 and flu, as well as attitudes and practices around vaccination
The Dangers of Influenza and COVID-19 in Adults with Chronic Health Conditions
Call to Action on the importance of protecting adults with chronic health conditions against flu during the COVID-19 pandemic (October 2020)
Respiratory Immunization Graphics
Graphics and sample social posts to help raise awareness about preventing COVID-19, flu, RSV, and pneumococcal disease
2024 National Survey: Attitudes and Behaviors about Influenza, COVID-19, Respiratory Syncytial Virus, and Pneumococcal Disease
2024 national survey on flu, RSV, COVID-19, and pneumococcal disease
Updated Recommendations for Respiratory Season
In this episode, NFID experts discuss updated recommendations to help protect against COVID-19, influenza (flu), respiratory syncytial virus (RSV), and pneumococcal disease …